Cardiovascular and all‐cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population

@article{Aro1991CardiovascularAA,
  title={Cardiovascular and all‐cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population},
  author={J. Aro},
  journal={The Prostate},
  year={1991},
  volume={18}
}
  • J. Aro
  • Published 1991
  • Medicine
  • The Prostate
Four hundred and seventy‐seven prospectively randomized patients with prostatic carcinoma were treated with a combination of intramuscular polyestradiol phosphate (PEP) and oral ethinyl estradiol, with intramuscular PEP alone, or with orchiectomy. The cardiovascular and all‐cause mortality of the two estrogen therapy modalities and orchiectomy were compared with those of the Finnish male population in general. The age‐standardized rate ratios (∼ relative risk) for cardiovascular mortality and… Expand
Advanced Prostate Cancer
Estrogens in the treatment of prostate cancer.
...
1
2
3
...

References

SHOWING 1-10 OF 23 REFERENCES
Cardiovascular complications in the treatment of prostatic carcinoma.
Treatment of prostatic carcinoma with polyestradiol phosphate combined with ethinylestradiol.
  • G. Jönsson
  • Medicine
  • Scandinavian journal of urology and nephrology
  • 1971
Hormonal Therapy of Prostatic Cancer
...
1
2
3
...